Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities

作者: Wakako Fujita , Ivone Gomes , Lakshmi A Devi

DOI: 10.1111/BPH.12663

关键词:

摘要: Several studies suggest that heteromerization between μ (MOP) and δ (DOP) opioid receptors modulates the signalling properties of individual receptors. For example, whereas activation MOP by an agonist induces G protein-mediated signalling, same β-arrestin-mediated in context MOP-DOP receptor heteromer. Moreover, heteromer-mediated is allosterically modulated a combination DOP ligands. This has implications analgesia given morphine-induced antinociception can be potentiated Recently reagents selectively targeting heteromer such as bivalent ligands, antibodies or membrane permeable peptides have been generated; these are enabling to elucidate contribution endogenously expressed heteromers well development side-effects associated with chronic use. Recent advances drug screening technology led identification heteromer-biased activates both signalling. this exhibits potent antinociceptive activity but reduced side-effects, suggesting ligands form basis for novel therapeutics treatment pain. In review, we summarize findings regarding biological functional characteristics vitro vivo heteromer-selective ligands. LINKED ARTICLES This article part themed section on Opioids: New Pathways Functional Selectivity. To view other articles visit http://dx.doi.org/10.1111/bph.2015.172.issue-2

参考文章(86)
A.K. Szentirmay, K.P. Király, N. Lenkey, E. Lackó, M. Al-Khrasani, T. Friedmann, J. Timár, S. Gyarmati, G. Tóth, S. Fürst, P. Riba, Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice. Brain Research Bulletin. ,vol. 90, pp. 66- 71 ,(2013) , 10.1016/J.BRAINRESBULL.2012.09.006
Leonard S. Dove, Anthony Lembo, Charles W. Randall, Ronald Fogel, David Andrae, J. Michael Davenport, Gail Mcintyre, June S. Almenoff, Paul S. Covington, Eluxadoline Benefits Patients With Irritable Bowel Syndrome With Diarrhea in a Phase 2 Study Gastroenterology. ,vol. 145, pp. 329- 338 ,(2013) , 10.1053/J.GASTRO.2013.04.006
I. Gomes, W. Fujita, A. Gupta, S. A. Saldanha, A. Negri, C. E. Pinello, C. Eberhart, E. Roberts, M. Filizola, P. Hodder, L. A. Devi, Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity Proceedings of the National Academy of Sciences of the United States of America. ,vol. 110, pp. 12072- 12077 ,(2013) , 10.1073/PNAS.1222044110
Ajay S. Yekkirala, Matthew L. Banks, Mary M. Lunzer, Stevens S. Negus, Kenner C. Rice, Philip S. Portoghese, Clinically employed opioid analgesics produce antinociception via μ-δ opioid receptor heteromers in Rhesus monkeys. ACS Chemical Neuroscience. ,vol. 3, pp. 720- 727 ,(2012) , 10.1021/CN300049M
Brigitte L. Kieffer, Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides Cellular and Molecular Neurobiology. ,vol. 15, pp. 615- 635 ,(1995) , 10.1007/BF02071128
H.-B. Wang, B. Zhao, Y.-Q. Zhong, K.-C. Li, Z.-Y. Li, Q. Wang, Y.-J. Lu, Z.-N. Zhang, S.-Q. He, H.-C. Zheng, S.-X. Wu, T. G. M. Hokfelt, L. Bao, X. Zhang, Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 13117- 13122 ,(2010) , 10.1073/PNAS.1008382107
Aashish Manglik, Andrew C. Kruse, Tong Sun Kobilka, Foon Sun Thian, Jesper M. Mathiesen, Roger K. Sunahara, Leonardo Pardo, William I. Weis, Brian K. Kobilka, Sébastien Granier, Crystal structure of the µ-opioid receptor bound to a morphinan antagonist Nature. ,vol. 485, pp. 321- 326 ,(2012) , 10.1038/NATURE10954
Ream Al-Hasani, Michael R. Bruchas, Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. ,vol. 115, pp. 1363- 1381 ,(2011) , 10.1097/ALN.0B013E318238BBA6